Company: CERO
Filing Date: 2025-02-07
Form Type: 424B3
Source: 0001213900-25-011071
Chunk: 305

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-02-07
Form: 424B3
Chunk 305
---
,251,020 shares of our Common Stock together with 2,551,020 Offered
Common Warrants to purchase 2,551,020 shares of Common Stock. Each share of Common Stock or Pre-Funded Warrant is being sold together
with an Offered Common Warrant to purchase one share of Common Stock. The shares of Common Stock or Pre-Funded Warrants and accompanying
Offered Common Warrants will be issued separately and will be immediately separable upon issuance but must be purchased together in this
offering. We are also registering the shares of Common Stock issuable from time to time upon exercise of the Offered Common Warrants and
Pre-Funded Warrants offered hereby.

Common Stock

The material terms and provisions
of our Common Stock are described under the caption “Description of Securities” in this prospectus and are incorporated herein
by reference.

Pre-Funded Warrants

The following summary of
certain terms and provisions of the Pre-Funded Warrants that are being offered hereby is not complete and is subject to, and qualified
in its entirety by, the provisions of the Pre-Funded Warrant, the form of which is filed as an exhibit to the registration statement
of which this prospectus forms a part. Prospective investors should carefully review the terms and provisions of the form of Pre-Funded
Warrant for a complete description of the terms and conditions of the Pre-Funded Warrants.

Duration and Exercise Price

Each Pre-Funded Warrant
offered hereby will have an initial exercise price per share equal to $0.0001. The Pre-Funded Warrants will be immediately exercisable
and may be exercised at any time until the Pre-Funded Warrants are exercised in full. The exercise price and number of shares of Common
Stock issuable upon exercise is subject to appropriate adjustment in the event of stock dividends, stock splits, reorganizations or similar
events affecting our Common Stock and the exercise price.

Exercisability

Each Pre-Funded Warrant
may be exercised at any time following the date of issuance and from time to time thereafter until the Pre-Funded Warrants are exercised
in full. The Pre-Funded Warrants will be exercisable in whole or in part by delivering to the Company a completed instruction form for
exercise and complying with the requirements for exercise set forth in the Pre-Funded Warrant. Payment of the exercise price may be made
in cash in which case the holder would receive upon such exercise the net number of shares of